{"id":"NCT02009163","sponsor":"Shire","briefTitle":"Evaluate the Maintenance of Efficacy of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder","officialTitle":"A Phase 3, Multicenter, Double-blind, Placebo-controlled, Randomized-withdrawal Study to Evaluate the Maintenance of Efficacy of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-01-27","primaryCompletion":"2015-04-08","completion":"2015-04-08","firstPosted":"2013-12-11","resultsPosted":"2016-04-01","lastUpdate":"2021-06-14"},"enrollment":418,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Binge Eating Disorder"],"interventions":[{"type":"DRUG","name":"Lisdexamfetamine dimesylate","otherNames":["SPD489","LDX"]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Lisdexamfetamine dimesylate","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"To evaluate maintenance of efficacy based on time to relapse between SPD489 (50 or 70mg) and placebo, as measured by the number of binge days (defined as days during which at least 1 binge episode occurs) per week as assessed by clinical interview based on subject diary and Clinical Global Impression - Severity (CGI-S) scores for patients who responded to SPD489 by the end of the Open-label Treatment Phase.","primaryOutcome":{"measure":"Time to Relapse From Date of Randomization to Endpoint of The Randomized-withdrawal Period","timeFrame":"Visit 21 (26 weeks after randomization [Week 38] or Early Termination)","effectByArm":[{"arm":"Placebo (Randomized-withdrawal Period)","deltaMin":null,"sd":null},{"arm":"SPD489 (Randomized-withdrawal Period)","deltaMin":null,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":53,"countries":["United States","Canada","Germany","Spain","Sweden"]},"refs":{"pmids":["32237290","28700805"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":411},"commonTop":["Dry mouth","Headache","Insomnia","Nausea","Nasopharyngitis"]}}